{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:54:29Z","timestamp":1788188069113,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Korean Neurological Association,South Korea","award":["KNA-21-Neuro-Frontier-Fellowship Award Grant-5,6"],"award-info":[{"award-number":["KNA-21-Neuro-Frontier-Fellowship Award Grant-5,6"]}]},{"DOI":"10.13039\/501100020621","name":"Seoul St. Mary's Hospital, Catholic University of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2017R1D1A1B06028086"],"award-info":[{"award-number":["NRF-2017R1D1A1B06028086"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s12035-024-04581-y","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T03:02:26Z","timestamp":1730170946000},"page":"4591-4604","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["MicroRNA-Targeted Gene Regulation in Salivary Gland Tissue of De Novo Parkinson\u2019s Disease Patients"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1752-2919","authenticated-orcid":false,"given":"Ko-Eun","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3745-5124","authenticated-orcid":false,"given":"Sang-Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3386-1208","authenticated-orcid":false,"given":"Jinhee","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3390-4607","authenticated-orcid":false,"given":"Dong-Woo","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1566-6265","authenticated-orcid":false,"given":"Yoonsang","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8087-7977","authenticated-orcid":false,"given":"Joong-Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,29]]},"reference":[{"issue":"5","key":"4581_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol 20(5):385\u2013397. https:\/\/doi.org\/10.1016\/S1474-4422(21)00030-2","journal-title":"Lancet Neurol"},{"issue":"1","key":"4581_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00441-018-2814-1","volume":"373","author":"JA Steiner","year":"2018","unstructured":"Steiner JA, Quansah E, Brundin P (2018) The concept of alpha-synuclein as a prion-like protein: ten years after. Cell Tissue Res 373(1):161\u2013173. https:\/\/doi.org\/10.1007\/s00441-018-2814-1","journal-title":"Cell Tissue Res"},{"issue":"7362","key":"4581_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature10324","volume":"477","author":"T Bartels","year":"2011","unstructured":"Bartels T, Choi JG (2011) Selkoe DJ (2011) \u03b1-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477(7362):107\u2013110. https:\/\/doi.org\/10.1038\/nature10324","journal-title":"Nature"},{"issue":"2","key":"4581_CR4","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1073\/pnas.97.2.571","volume":"97","author":"KA Conway","year":"2000","unstructured":"Conway KA, Lee SJ, Rochet JC, Ding TT, Williamson RE, Lansbury PT Jr (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson\u2019s disease: implications for pathogenesis and therapy. Proc Natl Acad Sci U S A 97(2):571\u2013576. https:\/\/doi.org\/10.1073\/pnas.97.2.571","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"4581_CR5","doi-asserted-by":"publisher","first-page":"e1267","DOI":"10.1212\/WNL.0000000000010404","volume":"95","author":"LM Chahine","year":"2020","unstructured":"Chahine LM, Beach TG, Brumm MC et al (2020) In vivo distribution of \u03b1-synuclein in multiple tissues and biofluids in Parkinson disease. Neurology 95(9):e1267\u2013e1284. https:\/\/doi.org\/10.1212\/WNL.0000000000010404","journal-title":"Neurology"},{"issue":"10","key":"4581_CR6","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1212\/WNL.0000000000000204","volume":"82","author":"CH Adler","year":"2014","unstructured":"Adler CH, Dugger BN, Hinni ML et al (2014) Submandibular gland needle biopsy for the diagnosis of Parkinson disease. Neurology 82(10):858\u2013864. https:\/\/doi.org\/10.1212\/WNL.0000000000000204","journal-title":"Neurology"},{"key":"4581_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.parkreldis.2018.04.019","volume":"58","author":"J Shin","year":"2019","unstructured":"Shin J, Park SH, Shin C et al (2019) Submandibular gland is a suitable site for alpha synuclein pathology in Parkinson disease. Parkinsonism Relat Disord 58:35\u201339. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.04.019","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"4581_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10072-016-2745-0","volume":"38","author":"JS Kim","year":"2017","unstructured":"Kim JS, Park IS, Park HE et al (2017) \u03b1-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects. Neurol Sci 38(1):171\u2013179. https:\/\/doi.org\/10.1007\/s10072-016-2745-0","journal-title":"Neurol Sci"},{"issue":"6","key":"4581_CR9","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1038\/s41591-023-02358-9","volume":"29","author":"A Okuzumi","year":"2023","unstructured":"Okuzumi A, Hatano T, Matsumoto G et al (2023) Propagative \u03b1-synuclein seeds as serum biomarkers for synucleinopathies. Nat Med 29(6):1448\u20131455. https:\/\/doi.org\/10.1038\/s41591-023-02358-9","journal-title":"Nat Med"},{"issue":"12","key":"4581_CR10","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL et al (2019) Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol 18(12):1091\u20131102. https:\/\/doi.org\/10.1016\/S1474-4422(19)30320-5","journal-title":"Lancet Neurol"},{"issue":"2","key":"4581_CR11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","volume":"19","author":"C Blauwendraat","year":"2020","unstructured":"Blauwendraat C, Nalls MA, Singleton AB (2020) The genetic architecture of Parkinson\u2019s disease. Lancet Neurol 19(2):170\u2013178. https:\/\/doi.org\/10.1016\/S1474-4422(19)30287-X","journal-title":"Lancet Neurol"},{"issue":"2","key":"4581_CR12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/mds.10683","volume":"19","author":"AE Kingsbury","year":"2004","unstructured":"Kingsbury AE, Daniel SE, Sangha H, Eisen S, Lees AJ, Foster OJ (2004) Alteration in alpha-synuclein mRNA expression in Parkinson\u2019s disease. Mov Disord 19(2):162\u2013170. https:\/\/doi.org\/10.1002\/mds.10683","journal-title":"Mov Disord"},{"issue":"10","key":"4581_CR13","doi-asserted-by":"publisher","first-page":"e7480","DOI":"10.1371\/journal.pone.0007480","volume":"4","author":"C Linnertz","year":"2009","unstructured":"Linnertz C, Saucier L, Ge D et al (2009) Genetic regulation of alpha-synuclein mRNA expression in various human brain tissues. PLoS ONE 4(10):e7480. https:\/\/doi.org\/10.1371\/journal.pone.0007480","journal-title":"PLoS ONE"},{"issue":"10","key":"4581_CR14","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1002\/mds.21007","volume":"21","author":"O Chiba-Falek","year":"2006","unstructured":"Chiba-Falek O, Lopez GJ, Nussbaum RL (2006) Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients. Mov Disord 21(10):1703\u20131708. https:\/\/doi.org\/10.1002\/mds.21007","journal-title":"Mov Disord"},{"issue":"7","key":"4581_CR15","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1002\/mds.21466","volume":"22","author":"S Papapetropoulos","year":"2007","unstructured":"Papapetropoulos S, Adi N, Mash DC, Shehadeh L, Bishopric N, Shehadeh L (2007) Expression of alpha-synuclein mRNA in Parkinson\u2019s disease. Mov Disord 22(7):1057\u20131059. https:\/\/doi.org\/10.1002\/mds.21466","journal-title":"Mov Disord"},{"key":"4581_CR16","doi-asserted-by":"publisher","first-page":"614212","DOI":"10.1155\/2012\/614212","volume":"2012","author":"A Dumitriu","year":"2012","unstructured":"Dumitriu A, Moser C, Hadzi TC et al (2012) Postmortem interval influences \u03b1-synuclein expression in Parkinson disease brain. Parkinsons Dis 2012:614212. https:\/\/doi.org\/10.1155\/2012\/614212","journal-title":"Parkinsons Dis"},{"issue":"14","key":"4581_CR17","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1056\/NEJMra1402513","volume":"378","author":"AP Feinberg","year":"2018","unstructured":"Feinberg AP (2018) The key role of epigenetics in human disease prevention and mitigation. N Engl J Med 378(14):1323\u20131334. https:\/\/doi.org\/10.1056\/NEJMra1402513","journal-title":"N Engl J Med"},{"issue":"12","key":"4581_CR18","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.3390\/ijms18122698","volume":"18","author":"L Leggio","year":"2017","unstructured":"Leggio L, Vivarelli S, L\u2019Episcopo F et al (2017) microRNAs in Parkinson\u2019s disease: from pathogenesis to novel diagnostic and therapeutic approaches. Int J Mol Sci 18(12):2698. https:\/\/doi.org\/10.3390\/ijms18122698","journal-title":"Int J Mol Sci"},{"issue":"19","key":"4581_CR19","doi-asserted-by":"publisher","first-page":"e1654","DOI":"10.1212\/WNL.0000000000005475","volume":"90","author":"G Pagano","year":"2018","unstructured":"Pagano G, Polychronis S, Wilson H et al (2018) Diabetes mellitus and Parkinson disease. Neurology 90(19):e1654\u2013e1662. https:\/\/doi.org\/10.1212\/WNL.0000000000005475","journal-title":"Neurology"},{"key":"4581_CR20","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3389\/fnins.2019.00868","volume":"13","author":"F Fiory","year":"2019","unstructured":"Fiory F, Perruolo G, Cimmino I et al (2019) The relevance of insulin action in the dopaminergic system. Front Neurosci 13:868. https:\/\/doi.org\/10.3389\/fnins.2019.00868","journal-title":"Front Neurosci"},{"issue":"2","key":"4581_CR21","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/ene.14070","volume":"27","author":"YS Oh","year":"2020","unstructured":"Oh YS, Kim JS, Yoo SW, Hwang EJ, Lyoo CH, Lee KS (2020) Gender difference in the effect of uric acid on striatal dopamine in early Parkinson\u2019s disease. Eur J Neurol 27(2):258\u2013264. https:\/\/doi.org\/10.1111\/ene.14070","journal-title":"Eur J Neurol"},{"issue":"4","key":"4581_CR22","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/ene.15698","volume":"30","author":"MI Maraki","year":"2023","unstructured":"Maraki MI, Yannakoulia M, Xiromerisiou G et al (2023) Mediterranean diet is associated with a lower probability of prodromal Parkinson\u2019s disease and risk for Parkinson\u2019s disease\/dementia with Lewy bodies: a longitudinal study. Eur J Neurol 30(4):934\u2013942. https:\/\/doi.org\/10.1111\/ene.15698","journal-title":"Eur J Neurol"},{"issue":"11","key":"4581_CR23","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S1474-4422(19)30285-6","volume":"18","author":"NM van der Kolk","year":"2019","unstructured":"van der Kolk NM, de Vries NM, Kessels RPC et al (2019) Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson\u2019s disease: a double-blind, randomised controlled trial. Lancet Neurol 18(11):998\u20131008. https:\/\/doi.org\/10.1016\/S1474-4422(19)30285-6","journal-title":"Lancet Neurol"},{"issue":"6","key":"4581_CR24","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","volume":"51","author":"WR Gibb","year":"1988","unstructured":"Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 51(6):745\u2013752. https:\/\/doi.org\/10.1136\/jnnp.51.6.745","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"4581_CR25","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"issue":"4","key":"4581_CR26","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3390\/nu12041102","volume":"12","author":"YJ Kwon","year":"2020","unstructured":"Kwon YJ, Lee H, Yoon Y, Kim HM, Chu SH, Lee JW (2020) Development and validation of a questionnaire to measure adherence to the Mediterranean diet in Korean adults. Nutrients 12(4):1102. https:\/\/doi.org\/10.3390\/nu12041102","journal-title":"Nutrients"},{"issue":"2","key":"4581_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0895-4356(93)90053-4","volume":"46","author":"RA Washburn","year":"1993","unstructured":"Washburn RA, Smith KW, Jette AM, Janney CA (1993) The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol 46(2):153\u2013162. https:\/\/doi.org\/10.1016\/0895-4356(93)90053-4","journal-title":"J Clin Epidemiol"},{"issue":"D1","key":"4581_CR28","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","volume":"47","author":"A Kozomara","year":"2019","unstructured":"Kozomara A, Birgaoanu M, Griffiths-Jones S (2019) miRBase: from microRNA sequences to function. Nucleic Acids Res 47(D1):D155\u2013D162. https:\/\/doi.org\/10.1093\/nar\/gky1141","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"4581_CR29","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrg2290","volume":"9","author":"W Filipowicz","year":"2008","unstructured":"Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9(2):102\u2013114. https:\/\/doi.org\/10.1038\/nrg2290","journal-title":"Nat Rev Genet"},{"issue":"4","key":"4581_CR30","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/1531-8249(200004)47:4<521::AID-ANA18>3.0.CO;2-B","volume":"47","author":"K Wakabayashi","year":"2000","unstructured":"Wakabayashi K, Engelender S, Yoshimoto M, Tsuji S, Ross CA, Takahashi H (2000) Synphilin-1 is present in Lewy bodies in Parkinson\u2019s disease. Ann Neurol 47(4):521\u2013523","journal-title":"Ann Neurol"},{"issue":"3","key":"4581_CR31","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.nbd.2007.03.007","volume":"26","author":"J Humbert","year":"2007","unstructured":"Humbert J, Beyer K, Carrato C, Mate JL, Ferrer I, Ariza A (2007) Parkin and synphilin-1 isoform expression changes in Lewy body diseases. Neurobiol Dis 26(3):681\u2013687. https:\/\/doi.org\/10.1016\/j.nbd.2007.03.007","journal-title":"Neurobiol Dis"},{"key":"4581_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-2350-9-19","volume":"9","author":"R Myhre","year":"2008","unstructured":"Myhre R, Klungland H, Farrer MJ, Aasly JO (2008) Genetic association study of synphilin-1 in idiopathic Parkinson\u2019s disease. BMC Med Genet 9:19. https:\/\/doi.org\/10.1186\/1471-2350-9-19","journal-title":"BMC Med Genet"},{"key":"4581_CR33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.neulet.2018.10.020","volume":"690","author":"T Shishido","year":"2019","unstructured":"Shishido T, Nagano Y, Araki M et al (2019) Synphilin-1 has neuroprotective effects on MPP+-induced Parkinson\u2019s disease model cells by inhibiting ROS production and apoptosis. Neurosci Lett 690:145\u2013150. https:\/\/doi.org\/10.1016\/j.neulet.2018.10.020","journal-title":"Neurosci Lett"},{"issue":"2","key":"4581_CR34","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.neuroscience.2009.10.042","volume":"165","author":"X Li","year":"2010","unstructured":"Li X, Liu Z, Tamashiro K et al (2010) Synphilin-1 exhibits trophic and protective effects against Rotenone toxicity. Neuroscience 165(2):455\u2013462. https:\/\/doi.org\/10.1016\/j.neuroscience.2009.10.042","journal-title":"Neuroscience"},{"issue":"11","key":"4581_CR35","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1093\/hmg\/ddq086","volume":"19","author":"WW Smith","year":"2010","unstructured":"Smith WW, Liu Z, Liang Y et al (2010) Synphilin-1 attenuates neuronal degeneration in the A53T alpha-synuclein transgenic mouse model. Hum Mol Genet 19(11):2087\u20132098. https:\/\/doi.org\/10.1093\/hmg\/ddq086","journal-title":"Hum Mol Genet"},{"issue":"10","key":"4581_CR36","doi-asserted-by":"publisher","first-page":"e13700","DOI":"10.1371\/journal.pone.0013700","volume":"5","author":"S B\u00fcttner","year":"2010","unstructured":"B\u00fcttner S, Delay C, Franssens V et al (2010) Synphilin-1 enhances \u03b1-synuclein aggregation in yeast and contributes to cellular stress and cell death in a Sir2-dependent manner. PLoS ONE 5(10):e13700. https:\/\/doi.org\/10.1371\/journal.pone.0013700","journal-title":"PLoS ONE"},{"issue":"15","key":"4581_CR37","doi-asserted-by":"publisher","first-page":"5917","DOI":"10.1073\/pnas.0509707103","volume":"103","author":"A Eyal","year":"2006","unstructured":"Eyal A, Szargel R, Avraham E et al (2006) Synphilin-1A: an aggregation-prone isoform of synphilin-1 that causes neuronal death and is present in aggregates from alpha-synucleinopathy patients. Proc Natl Acad Sci U S A 103(15):5917\u20135922. https:\/\/doi.org\/10.1073\/pnas.0509707103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"4581_CR38","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/hmg\/ddt467","volume":"23","author":"N Casadei","year":"2014","unstructured":"Casadei N, P\u00f6hler AM, Tom\u00e1s-Zapico C et al (2014) Overexpression of synphilin-1 promotes clearance of soluble and misfolded alpha-synuclein without restoring the motor phenotype in aged A30P transgenic mice. Hum Mol Genet 23(3):767\u2013781. https:\/\/doi.org\/10.1093\/hmg\/ddt467","journal-title":"Hum Mol Genet"},{"issue":"1","key":"4581_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s43440-021-00340-1","volume":"74","author":"KZ Kuter","year":"2022","unstructured":"Kuter KZ, \u015amia\u0142owska M, Ossowska K (2022) The influence of preconditioning with low dose of LPS on paraquat-induced neurotoxicity, microglia activation and expression of \u03b1-synuclein and synphilin-1 in the dopaminergic system. Pharmacol Rep 74(1):67\u201383. https:\/\/doi.org\/10.1007\/s43440-021-00340-1","journal-title":"Pharmacol Rep"},{"issue":"8","key":"4581_CR40","doi-asserted-by":"publisher","first-page":"6834","DOI":"10.1074\/jbc.M312760200","volume":"279","author":"G Lee","year":"2004","unstructured":"Lee G, Tanaka M, Park K et al (2004) Casein kinase II-mediated phosphorylation regulates alpha-synuclein\/synphilin-1 interaction and inclusion body formation. J Biol Chem 279(8):6834\u20136839. https:\/\/doi.org\/10.1074\/jbc.M312760200","journal-title":"J Biol Chem"},{"issue":"6","key":"4581_CR41","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.1074\/jbc.M310994200","volume":"279","author":"M Tanaka","year":"2004","unstructured":"Tanaka M, Kim YM, Lee G, Junn E, Iwatsubo T, Mouradian MM (2004) Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective. J Biol Chem 279(6):4625\u20134631. https:\/\/doi.org\/10.1074\/jbc.M310994200","journal-title":"J Biol Chem"},{"issue":"4","key":"4581_CR42","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/hmg\/ddv504","volume":"25","author":"J Liu","year":"2016","unstructured":"Liu J, Li T, Thomas JM et al (2016) Synphilin-1 attenuates mutant LRRK2-induced neurodegeneration in Parkinson\u2019s disease models. Hum Mol Genet 25(4):672\u2013680. https:\/\/doi.org\/10.1093\/hmg\/ddv504","journal-title":"Hum Mol Genet"},{"issue":"2","key":"4581_CR43","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24(2):197\u2013211. https:\/\/doi.org\/10.1016\/s0197-4580(02)00065-9","journal-title":"Neurobiol Aging"},{"key":"4581_CR44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fneur.2017.00037","volume":"8","author":"CD Rietdijk","year":"2017","unstructured":"Rietdijk CD, Perez-Pardo P, Garssen J, van Wezel RJ, Kraneveld AD (2017) Exploring Braak\u2019s hypothesis of Parkinson\u2019s disease. Front Neurol 8:37. https:\/\/doi.org\/10.3389\/fneur.2017.00037","journal-title":"Front Neurol"},{"issue":"1","key":"4581_CR45","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, R\u00fcb U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res 318(1):121\u2013134. https:\/\/doi.org\/10.1007\/s00441-004-0956-9","journal-title":"Cell Tissue Res"},{"issue":"3","key":"4581_CR46","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/brain\/awab446","volume":"145","author":"S Smaji\u0107","year":"2022","unstructured":"Smaji\u0107 S, Prada-Medina CA, Landoulsi Z et al (2022) Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state. Brain 145(3):964\u2013978. https:\/\/doi.org\/10.1093\/brain\/awab446","journal-title":"Brain"},{"issue":"4","key":"4581_CR47","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3390\/biomedicines9040368","volume":"9","author":"SX Ma","year":"2021","unstructured":"Ma SX, Lim SB (2021) Single-cell RNA sequencing in Parkinson\u2019s disease. Biomedicines 9(4):368. https:\/\/doi.org\/10.3390\/biomedicines9040368","journal-title":"Biomedicines"},{"issue":"2","key":"4581_CR48","doi-asserted-by":"publisher","first-page":"108263","DOI":"10.1016\/j.celrep.2020.108263","volume":"33","author":"HJR Fernandes","year":"2020","unstructured":"Fernandes HJR, Patikas N, Foskolou S et al (2020) Single-cell transcriptomics of Parkinson\u2019s disease human in vitro models reveals dopamine neuron-specific stress responses. Cell Rep 33(2):108263. https:\/\/doi.org\/10.1016\/j.celrep.2020.108263","journal-title":"Cell Rep"},{"key":"4581_CR49","doi-asserted-by":"publisher","first-page":"686739","DOI":"10.3389\/fgene.2022.686739","volume":"13","author":"J Huang","year":"2022","unstructured":"Huang J, Liu L, Qin L, Huang H, Li X (2022) Single-cell transcriptomics uncovers cellular heterogeneity, mechanisms, and therapeutic targets for Parkinson\u2019s disease. Front Genet 13:686739. https:\/\/doi.org\/10.3389\/fgene.2022.686739","journal-title":"Front Genet"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04581-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04581-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04581-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:09:15Z","timestamp":1741082955000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04581-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,29]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["4581"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04581-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,29]]},"assertion":[{"value":"24 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the institutional review board of Seoul St. Mary\u2019s Hospital, The Catholic University of Korea (IRB approval no. KC22TISI0415). All experiments were conducted in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board Statement"}},{"value":"All subjects provided written informed consent to participate.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}